Liver fat content was 13±7%, ALT levels 55±33 UL−1, HbA1c 6.0±0.8% and fasting glucose 5.4±1.6 mmol/L in the NAFLD group. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.